Home » Topics » Regulatory » Patents

Patents
RSS

Tricyclic compounds inhibiting protein farnesyltransferase claimed by Schering-Plough

April 21, 1998

Conjugates for imaging vascular thrombi developed at NeoRx/U. of Washington

April 20, 1998

P&U claims new distamycin derivatives and their use as antitumor and antiviral agents

April 20, 1998

Chiesi prepares new anticonvulsants and neuroprotective agents

April 20, 1998

COX-2 inhibitors claimed by AHP for arthritis, cancer and AD

April 20, 1998

Novel cell adhesion inhibitors discovered at Biogen

April 20, 1998

Synthetic dolastatin derivatives as antitumor agents

April 20, 1998

New endothelin antagonists from Bristol-Myers Squibb

April 20, 1998

ICAgen and Lilly disclose potassium channel inhibitors

April 17, 1998

Agents for urinary incontinence and IBS in development at Pharmacia & Upjohn

April 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...